Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK and MMV collaborate in malaria treatment
Under the new agreement, Medicines for Malaria Venture (MMV) will provide funding for research to be performed at GlaxoSmithKline (GSK). Research will focus on macrolide antibiotics, based on
Under the new agreement, Medicines for Malaria Venture (MMV) will provide funding for research to be performed at GlaxoSmithKline (GSK). Research will focus on macrolide antibiotics, based on
The FDA approval was based on results from a Phase III clinical study conducted with more than 600 patients that found once-daily Moxatag for 10 days was effective
The label will be revised to state that available data indicate that rosiglitazone may be associated with an increased risk of myocardial ischaemic events. It will also state
This approval represents initiation of the first clinical sites for the pivotal study and permits commencement of screening for suitable patients. This approval is claimed to be the
In 2006, Paradigm Medical resolved two suits filed by former employees via summary judgments in favor of the company. Paradigm Medical has resolved several class-action suits out of
This approval grants seven years of US market exclusivity to Mobius, once its new drug application is approved. Ed Timm, president of Mobius, said: “Orphan drug status is
Lansoprazole delayed-release capsules are generic version of Tap Pharmaceutical’s gastric-acid pump inhibitor, Prevacid (lansoprazole) delayed-release capsules. According to IMS sales data, the brand product had annual sales of
Under terms of the previously executed memorandum of understanding (MOU) with Seafarer, Organetix is required to contribute a minimum of $150,000 and a maximum of $600,000 to the
According to the invention of this patent disclosure, the compounds are useful in the treatment of neurodegenerative disorders like Alzheimer’s, Parkinson, Schizophrenia and Huntington’s. Venkat Jasti, CEO of
Available by prescription, the adhesive patch delivers medication directly to the site of pain and is said to offer a safe and effective alternative to widely used nonsteroidal